Close

Canaccord Genuity Reiterates a 'Buy' on Immunogen (IMGN); Raising PT Oct 31, 2011 08:22AM
Canaccord Genuity Maintains a 'Buy' on Immunogen (IMGN); Breakthrough P2 Results Support High T-DM1 Potential Sep 26, 2011 08:45AM
Canaccord Genuity Maintains a 'Buy' on Immunogen (IMGN); 2012 A Pivotal Year Aug 18, 2011 09:21AM
Canaccord Genuity on ImmunoGen (IMGN): Keeping Abreast of Things Apr 8, 2011 02:41PM
Canaccord Genuity Morning Coffee on Immunogen (IMGN): Not So Much Jan 31, 2011 10:19AM


Dec 28, 2010 09:35AM Canaccord Genuity on Life Sciences/Biotechnology: Selected Small Cap Biotech Roundup